OKYO Pharma Limited (OKYO)

OKYO Pharma Statistics

Total Valuation

OKYO Pharma has a market cap or net worth of $83.44 million. The enterprise value is $79.41 million.

Market Cap	83.44M
Enterprise Value	79.41M

Important Dates

The last earnings date was Friday, July 18, 2025, before market open.

Earnings Date	Jul 18, 2025
Ex-Dividend Date	n/a

Share Statistics

OKYO Pharma has 52.48 million shares outstanding. The number of shares has increased by 24.46% in one year.

Current Share Class	52.48M
Shares Outstanding	52.48M
Shares Change (YoY)	+24.46%
Shares Change (QoQ)	-17.58%
Owned by Insiders (%)	31.26%
Owned by Institutions (%)	1.29%
Float	32.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.58

Current Ratio	0.58
Quick Ratio	0.53
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-31.84

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-104.63%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	183.14%
Weighted Average Cost of Capital (WACC)	3.78%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	4
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	-1.85M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +52.89% in the last 52 weeks. The beta is -0.12, so OKYO Pharma's price volatility has been lower than the market average.

Beta (5Y)	-0.12
52-Week Price Change	+52.89%
50-Day Moving Average	1.76
200-Day Moving Average	2.21
Relative Strength Index (RSI)	44.43
Average Volume (20 Days)	84,791

Short Selling Information

The latest short interest is 275,291, so 0.52% of the outstanding shares have been sold short.

Short Interest	275,291
Short Previous Month	435,430
Short % of Shares Out	0.52%
Short % of Float	0.86%
Short Ratio (days to cover)	0.81

Income Statement

Revenue	n/a
Gross Profit	-6.26M
Operating Income	-6.25M
Pretax Income	-6.46M
Net Income	-4.61M
EBITDA	-6.25M
EBIT	-6.25M
Earnings Per Share (EPS)	-$0.11

Balance Sheet

The company has $4.22 million in cash and $185,795 in debt, with a net cash position of $4.03 million or $0.08 per share.

Cash & Cash Equivalents	4.22M
Total Debt	185,795
Net Cash	4.03M
Net Cash Per Share	$0.08
Equity (Book Value)	-3.42M
Book Value Per Share	-0.09
Working Capital	-3.42M

Cash Flow

In the last 12 months, operating cash flow was -$3.10 million and capital expenditures -$1,208, giving a free cash flow of -$3.10 million.

Operating Cash Flow	-3.10M
Capital Expenditures	-1,208
Depreciation & Amortization	2,256
Net Borrowing	948,192
Free Cash Flow	-3.10M
FCF Per Share	-$0.06

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

OKYO Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.46%
Shareholder Yield	-24.46%
Earnings Yield	-5.53%
FCF Yield	-3.71%

Analyst Forecast

The average price target for OKYO Pharma is $6.33, which is 298.11% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$6.33
Price Target Difference	298.11%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 22, 2023. It was a reverse split with a ratio of 1:65.

Last Split Date	May 22, 2023
Split Type	Reverse
Split Ratio	1:65

Scores

Altman Z-Score	n/a
Piotroski F-Score	2